We are live on ! Find out more
NYLIM

New York Life Investment Management Portfolio holdings

AUM $14.3B
1-Year Est. Return 34.42%
This Fund
S&P 500
This Quarter Est. Return
+3.62%
1 Year Est. Return
+34.42%
3 Year Est. Return
+100.17%
5 Year Est. Return
+116.66%
10 Year Est. Return
+182.12%
AUM
$9.95B
AUM Growth
-$98.8M
Cap. Flow
-$314M
Cap. Flow %
-3.16%
Top 10 Hldgs %
27.38%
Holding
1,383
New
56
Increased
543
Reduced
236
Closed
536
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IRT icon
776
Independence Realty Trust
IRT
$4.01B
$641K 0.01%
34,228
-20,650
-38% -$345K
DELL icon
777
Dell
DELL
$320B
$640K 0.01%
4,640
+328
+8% +$44K
XRAY icon
778
Dentsply Sirona
XRAY
$2.31B
$629K 0.01%
25,253
-6,632
-21% -$190K
POST icon
779
Post Holdings
POST
$3.65B
$625K 0.01%
6,001
+586
+11% +$61K
NE icon
780
Noble Corp
NE
$7.07B
$624K 0.01%
+13,985
New +$646K
TKR icon
781
Timken Company
TKR
$9.1B
$620K 0.01%
7,743
+1,390
+22% +$120K
AMG icon
782
Affiliated Managers Group
AMG
$9.7B
$616K 0.01%
3,941
-1,935
-33% -$308K
ATKR icon
783
Atkore
ATKR
$3.17B
$610K 0.01%
4,519
+784
+21% +$125K
AM icon
784
Antero Midstream
AM
$10.5B
$609K 0.01%
41,319
+7,596
+23% +$109K
BC icon
785
Brunswick
BC
$5.29B
$607K 0.01%
+8,342
New +$681K
WTS icon
786
Watts Water Technologies
WTS
$12.8B
$605K 0.01%
3,299
-1,122
-25% -$225K
PATH icon
787
UiPath
PATH
$8.64B
$601K 0.01%
47,420
+2,491
+6% +$43.1K
SON icon
788
Sonoco
SON
$5.77B
$601K 0.01%
11,853
+2,115
+22% +$122K
VKTX icon
789
Viking Therapeutics
VKTX
$3.84B
$599K 0.01%
+11,306
New +$741K
IBP icon
790
Installed Building Products
IBP
$6.54B
$595K 0.01%
+2,891
New +$651K
OPCH icon
791
Option Care Health
OPCH
$3.61B
$585K 0.01%
21,136
+2,409
+13% +$71.8K
ACWI icon
792
iShares MSCI ACWI ETF
ACWI
$33.6B
$578K 0.01%
5,143
+333
+7% +$36.6K
GAP
793
The Gap Inc
GAP
$7.34B
$576K 0.01%
24,129
+2,354
+11% +$54.7K
DLB icon
794
Dolby
DLB
$5.84B
$571K 0.01%
7,210
+703
+11% +$56.5K
SBRA icon
795
Sabra Healthcare REIT
SBRA
$5.15B
$554K 0.01%
35,976
+2,703
+8% +$38.6K
ALNY icon
796
Alnylam Pharmaceuticals
ALNY
$30.4B
$550K 0.01%
2,263
+45
+2% +$7.1K
CTRE icon
797
CareTrust REIT
CTRE
$9.18B
$547K 0.01%
21,810
+3,051
+16% +$75.6K
SUM
798
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
$532K 0.01%
14,532
+6,327
+77% +$248K
COTY icon
799
Coty
COTY
$2.42B
$529K 0.01%
52,747
+13,356
+34% +$143K
AN icon
800
AutoNation
AN
$6.89B
$517K 0.01%
3,246
+267
+9% +$43.6K

Similar funds

New York Life Investment Management's Q2 2024 Portfolio in Review

As of Q2 2024, New York Life Investment Management held 1,383 positions worth $9.95B, down 0.98% from $10B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

New York Life Investment Management withdrew a net $314M in Q2 2024, closing 536 positions and reducing 236 holdings. Its most notable exit was IndexIQ ETF Trust IQ U.S. Small Cap ETF, an estimated $136M position sold in full.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.

Against the trend, New York Life Investment Management opened a new position in IQ MacKay Securitized Income ETF worth $97.4M.

  • New York Life Investment Management's largest Q2 2024 buy was IQ MacKay Securitized Income ETF: 3,824,639 shares worth $97.4M.
  • New York Life Investment Management added most to IQ Candriam US Mid Cap Equity ETF in Q2 2024, an estimated $36M increase.
  • New York Life Investment Management's biggest Q2 2024 reduction was Invesco Senior Loan ETF, cutting an estimated $59.4M.
  • New York Life Investment Management fully exited IndexIQ ETF Trust IQ U.S. Small Cap ETF in Q2 2024, selling an estimated $136M.
  • New York Life Investment Management's ten largest holdings make up 27% of its $9.95B portfolio in Q2 2024.
  • New York Life Investment Management opened 56 new positions and closed 536 in Q2 2024.
  • New York Life Investment Management's portfolio value fell 0.98% quarter-over-quarter to $9.95B.

Based on New York Life Investment Management's 13F filing for Q2 2024, filed 5 Aug 2024.